Interleukin inhibitors represent a category of biopharmaceutical agents aimed at disrupting the function of interleukins, a subset of cytokines (signalling molecules) generated by white blood cells. Interleukins are pivotal in managing immune reactions, inflammation, and haematopoiesis (the production of blood cells). In various autoimmune and inflammatory conditions, including rheumatoid...